SCHEMBL24961877

SCHEMBL24961877

C#Cc1ccc2cc(OCCCCCCO)ccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE2A O00408 1/20 0.42
▸ PDE3B Q13370 1/20 0.42
▸ PDE3A Q14432 1/20 0.42
▸ P2RY12 Q9H244 1/20 0.42
▸ HDAC1 Q13547 3/20 0.40
▸ PDK2 Q15119 3/20 0.39
▸ XDH P47989 1/20 0.39
▸ MAOA P21397 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ HDAC3 O15379 2/20 0.38
▸ HDAC4 P56524 2/20 0.38
▸ HDAC7 Q8WUI4 2/20 0.38
▸ HDAC2 Q92769 2/20 0.38
▸ HDAC10 Q969S8 2/20 0.38
▸ HDAC11 Q96DB2 2/20 0.38
▸ HDAC8 Q9BY41 2/20 0.38
▸ HDAC6 Q9UBN7 2/20 0.38
▸ HDAC9 Q9UKV0 2/20 0.38
▸ HDAC5 Q9UQL6 2/20 0.38
▸ EGFR P00533 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24961870 1.00 PDE2A (0.42) PDE2APDE3BPDE3AP2RY12HDAC1
SCHEMBL30456834 1.00 PDE2A (0.42) PDE2APDE3BPDE3AP2RY12HDAC1
SCHEMBL30754664 1.00 PDE2A (0.42) PDE2APDE3BPDE3AP2RY12HDAC1
SCHEMBL24962708 1.00 PDE2A (0.42) PDE2APDE3BPDE3AP2RY12HDAC1
SCHEMBL30754666 1.00 PDE2A (0.42) PDE2APDE3BPDE3AP2RY12HDAC1
SCHEMBL24962608 0.94 PDE2A (0.42) PDE2APDE3BPDE3AP2RY12HDAC1
SCHEMBL30754665 0.94 PDE2A (0.42) PDE2APDE3BPDE3AP2RY12HDAC1
SCHEMBL6727999 0.87 PRMT1 (0.43) MAOAMAOBHRH3TDP1
SCHEMBL6046899 0.87 PRMT1 (0.43) MAOAMAOBHRH3TDP1
SCHEMBL19342431 0.85 ALDH1A1 (0.42) MAOAHRH3TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085241-A1 LIQUID CRYSTAL COMPOUNDS Rolic Technologies AG (CH) 2026-03-26 — — US disclosed
US-12534670-B2 Liquid crystal compounds Rolic Technologies AG (CH) 2026-01-27 — — US disclosed
EP-4594446-A1 LIQUID CRYSTAL COMPOUNDS Rolic Technologies AG (CH) 2025-08-06 — — EP disclosed
US-20250066666-A1 LIQUID CRYSTAL COMPOUNDS Rolic Technologies AG (CH) 2025-02-27 — — US disclosed
EP-4444822-A1 LIQUID CRYSTAL COMPOUNDS Rolic Technologies AG (CH) 2024-10-16 — — EP disclosed
CN-118318024-A Liquid crystal compound 罗利克技术有限公司 2024-07-09 — — CN disclosed
WO-2024068311-A1 LIQUID CRYSTAL COMPOUNDS Rolic Technologies AG (CH) 2024-04-04 — — WO disclosed
CN-117500898-A Liquid crystal compound 罗利克技术有限公司 2024-02-02 — — CN disclosed
WO-2023104545-A1 LIQUID CRYSTAL COMPOUNDS Rolic Technologies AG (CH) 2023-06-15 — — WO disclosed
WO-2023006599-A1 LIQUID CRYSTAL COMPOUNDS Rolic Technologies AG (CH) 2023-02-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260085241-A1 LIQUID CRYSTAL COMPOUNDS SCO2, CCRL2, OGFRL1 PDE2A 4570/4885PDE3B 4540/4885PDE3A 4674/4885
US-12534670-B2 Liquid crystal compounds SCO2, LBR, C1R PDE2A 4524/4885PDE3B 4360/4885PDE3A 4582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback